Skip to main content
Fig. 2 | BMC Bioinformatics

Fig. 2

From: Pan-cancer analysis of SYNGR2 with a focus on clinical implications and immune landscape in liver hepatocellular carcinoma

Fig. 2

The expression of SYNGR2 in pan-cancer and different pathological stages. A. Differential expression of SYNGR2 in normal and tumor samples of 33 tumors in The Cancer Genome Atlas (TCGA) database. B. Data from TCGA and Genotype-Tissue Expression (GTEx) database showed differential expression of SYNGR2 in multiple cancers. C. Differential expression of SYNGR2 in cancers and normal tissues from TCGA dataset. D. T-SNE plot showing the expression of SYNGR2 in human tissue. E. Expression of SYNGR2 in different pathological stages of indicated tumors. F. SYNGR2 protein expression levels between tumor and respective normal tissues for 8 types of cancers. *p < 0.05, **p < 0.01, and ***p < 0.001

Back to article page

BMC Bioinformatics

ISSN: 1471-2105

Contact us